Clinical Trials Browser

OTHER × Antineoplastic Agents × Breast × Clear all

NCT03591276 2020-10-23

KEYDOX

Phase 1/2 Recruiting

Breast Neoplasms

NCT03799679 2019-01-10

Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer

Phase 4 Unknown

Triple Negative Breast Neoplasms